114 related articles for article (PubMed ID: 31633491)
21. Insufficient spectral quality to draw conclusions.
Boesch C; Vermathen P; Kreis R
Radiology; 2009 Mar; 250(3):955-6; author reply 955-6; discussion 956. PubMed ID: 19244058
[No Abstract] [Full Text] [Related]
22. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
[TBL] [Abstract][Full Text] [Related]
23. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases.
Thompson LD
Am J Surg Pathol; 2002 May; 26(5):551-66. PubMed ID: 11979086
[TBL] [Abstract][Full Text] [Related]
24. Routine genetic screening with a multi-gene panel in patients with pheochromocytomas.
Sbardella E; Cranston T; Isidori AM; Shine B; Pal A; Jafar-Mohammadi B; Sadler G; Mihai R; Grossman AB
Endocrine; 2018 Jan; 59(1):175-182. PubMed ID: 28477304
[TBL] [Abstract][Full Text] [Related]
25. USP10 Expression in Normal Adrenal Gland and Various Adrenal Tumors.
Zeng Z; Zhou Z; Zhan N; Yuan J; Ye B; Gu L; Wang J; Jian Z; Xiong X
Endocr Pathol; 2015 Dec; 26(4):302-8. PubMed ID: 26555087
[TBL] [Abstract][Full Text] [Related]
26. Germ-line mutations in nonsyndromic pheochromocytoma.
Neumann HP; Bausch B; McWhinney SR; Bender BU; Gimm O; Franke G; Schipper J; Klisch J; Altehoefer C; Zerres K; Januszewicz A; Eng C; Smith WM; Munk R; Manz T; Glaesker S; Apel TW; Treier M; Reineke M; Walz MK; Hoang-Vu C; Brauckhoff M; Klein-Franke A; Klose P; Schmidt H; Maier-Woelfle M; Peçzkowska M; Szmigielski C; Eng C;
N Engl J Med; 2002 May; 346(19):1459-66. PubMed ID: 12000816
[TBL] [Abstract][Full Text] [Related]
27. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.
Opocher G; Conton P; Schiavi F; Macino B; Mantero F
Fam Cancer; 2005; 4(1):13-6. PubMed ID: 15883705
[TBL] [Abstract][Full Text] [Related]
28. Patients with RET D631Y mutations most commonly present with pheochromocytoma and not medullary thyroid carcinoma.
Elston MS; Meyer-Rochow GY; Holdaway I; Conaglen JV
Horm Metab Res; 2012 May; 44(5):339-42. PubMed ID: 22274720
[TBL] [Abstract][Full Text] [Related]
29. Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas.
Kim KY; Kim JH; Hong AR; Seong MW; Lee KE; Kim SJ; Kim SW; Shin CS; Kim SY
PLoS One; 2016; 11(12):e0168413. PubMed ID: 27992508
[TBL] [Abstract][Full Text] [Related]
30. [Expression and clinical significance of survivin and PTEN in adrenal tumors].
Qin ZK; Zhou FJ; Dai YP; Chen W; Hou JH; Han H; Liu ZW; Yu SL; Zhang DZ; Yang JA
Ai Zheng; 2007 Oct; 26(10):1143-7. PubMed ID: 17927889
[TBL] [Abstract][Full Text] [Related]
31. Adrenal masses: characterization with in vivo proton MR spectroscopy--initial experience.
Faria JF; Goldman SM; Szejnfeld J; Melo H; Kater C; Kenney P; Huayllas MP; Demarchi G; Francisco VV; Andreoni C; Srougi M; Ortiz V; Abdalla N
Radiology; 2007 Dec; 245(3):788-97. PubMed ID: 18024453
[TBL] [Abstract][Full Text] [Related]
32. Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases.
Duregon E; Volante M; Bollito E; Goia M; Buttigliero C; Zaggia B; Berruti A; Scagliotti GV; Papotti M
Hum Pathol; 2015 Dec; 46(12):1799-807. PubMed ID: 26472162
[TBL] [Abstract][Full Text] [Related]
33. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
Pollard PJ; El-Bahrawy M; Poulsom R; Elia G; Killick P; Kelly G; Hunt T; Jeffery R; Seedhar P; Barwell J; Latif F; Gleeson MJ; Hodgson SV; Stamp GW; Tomlinson IP; Maher ER
J Clin Endocrinol Metab; 2006 Nov; 91(11):4593-8. PubMed ID: 16954163
[TBL] [Abstract][Full Text] [Related]
34. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.
Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N
Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324
[TBL] [Abstract][Full Text] [Related]
35. RET expression and neuron-like differentiation of pheochromocytoma and normal chromaffin cells.
Powers JF; Picard KL; Tischler AS
Horm Metab Res; 2009 Sep; 41(9):710-4. PubMed ID: 19551609
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical expression of Ki67, c-erbB-2, and c-kit antigens in benign and malignant pheochromocytoma.
Tavangar SM; Shojaee A; Moradi Tabriz H; Haghpanah V; Larijani B; Heshmat R; Lashkari A; Azimi S
Pathol Res Pract; 2010 May; 206(5):305-9. PubMed ID: 20189725
[TBL] [Abstract][Full Text] [Related]
37. PHEOCHROMOCYTOMA: A GENETIC AND DIAGNOSTIC UPDATE.
Mercado-Asis LB; Wolf KI; Jochmanova I; Taïeb D
Endocr Pract; 2018 Jan; 24(1):78-90. PubMed ID: 29144820
[TBL] [Abstract][Full Text] [Related]
38. The RET proto-oncogene in sporadic pheochromocytomas.
Takaya K; Yoshimasa T; Arai H; Tamura N; Miyamoto Y; Itoh H; Nakao K
Intern Med; 1996 Jun; 35(6):449-52. PubMed ID: 8835594
[TBL] [Abstract][Full Text] [Related]
39. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
Nesković G; Stanojević B; Palmar I; Dimitrijević B
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
[TBL] [Abstract][Full Text] [Related]
40. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
Martins AF; Martins JM; do Vale S; Dias T; Silveira C; da Silva IR; Carmo-Fonseca M
Hormones (Athens); 2016 Jul; 15(3):435-440. PubMed ID: 27838608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
